UNIPRINT.NET-CORP.
UniPrint.net Corp. (www.uniprint.net ), the innovative leader in printing virtualization for server-centric and cloud environments, today announced the appointment of Steven Jones as EMEA Regional Director. Mr. Jones will be responsible for building on UniPrint’s impressive sales record and successful customer experience for its award-winning Infinity Suite of printing solutions, as well as the company’s expansion across Europe, Middle East and Africa.
“We are extremely pleased and excited to have Steve on board. Steve is a proven team builder and thought leader in the industry,“ said David Fung, Managing Partner & CEO at UniPrint.net. “As we continue to innovate and redefine digital printing, we require the best people like Steve who understands the digital transformation journey to support our growth strategy.”
Mr. Jones has over 20 years of print market experience with the onus on software-based print solutions. In recent time, he has focused on his ‘Software-defined Print Solution’ ideology leading to the creation of an agnostic approach to the managed print services market. His belief is that print is not just about pieces of paper, but more about the digital life and opportunity of an application’s print function.
“With the IT market currently focusing on the omni-channel digital user experience, UniPrint is the best technology today to meet the demands of print in this space,” commented Mr. Jones. “UniPrint’s vision for creating innovative technology aligns with my own for the independent print solution market making it a perfect fit. It’s a fantastic opportunity for me to join the UniPrint management team.”
The UniPrint Infinity Suite is designed to solve printing issues for enterprises operating in complex and virtualized IT environments. Its simple design – one universal printer driver and one virtual print queue built on one management platform, supports any server platform, operating system, client platform and printer hardware. UniPrint Infinity printing solution enables error-free mobile and cloud printing with security ; simplifies print management; and optimizes the use of available bandwidth across networks for improved end user experience and ROI.
For further information on the UniPrint Infinity Suite or for a free product trial, visit www.uniprint.net .
About UniPrint.net Corp.
UniPrint.net Corp. is the innovator
leader in printing virtualization. The newest solution in UniPrint’s
patented, award-winning product line, UniPrint Infinity is the
industry’s first truly secure enterprise-wide solution for any computing
environment. Enabling anywhere, anytime, and any device secure pull
printing, UniPrint Infinity comes with a proven ROI through its
statistics module, print document archiving functionality, secure mobile
printing modules, and high availability setup with load balancing
capability. UniPrint Infinity replaces all manufacturer printer drivers
with a single PDF generator to promote faster, more efficient printing,
helping organizations to improve both productivity and return on
investments.
UniPrint™ and UniPrint Infinity™ are the trademarks of UniPrint.net. All other trademarks and registered trademarks are properties of their respective owners.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160914005205/en/
Contact:
UniPrint.net Corp.
Media Contact:
Katherine
Cheung, +1 416-503-9800 x8566
Katherine.cheung@uniprint.net
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years18.6.2025 07:00:00 CEST | Press release
An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV International Congress of Dermatology (ICD) found that Nemluvio was well tolerated and associated with sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, including both skin lesions and itch, up to two years1 Results build on data from OLYMPIA – the largest completed pivotal clinical program in prurigo nodularis and the only one assessing long-term safety and efficacy in prurigo nodularis1-3 This follows the presentation of data from the ARCADIA long-term extension study at the Revolutionizing Atopic Dermatitis (RAD) Conference earlier this month, which showed Nemluvio is well tolerated with sustained and increased improvements in efficacy outcomes in atopic dermatitis patients up to two years4 Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy o
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 06:30:00 CEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 03:30:00 CEST | Press release
Maximizing synergies to accelerate the global expansion of biometric info-driven government authentication and security business Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contr
DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Production Capacity by 15%18.6.2025 03:20:00 CEST | Press release
- To accommodate large-scale TVs and high-end model demands - Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the September operational launch of a coating device compatible with 2,500 mm-width high functional optical film at our Mihara Plant in Hiroshima Prefecture. The operational launch of the second wide coating device comes in response to market and consumer needs, and will boost production capacity by more than 15% on an area basis. With the increased capacity, DNP will accommodate the demand for high functional optical film for 65-inch large-screen TVs, with horizontal and vertical dimensions of 1,436.4 mm x 809.0 mm, which are expected to increase at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 20301 on an area basis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613720341/en/ Image of Mihara Plant [Features] Facilitates the efficient manufacture, or imposition, of high fun
Alipay Enables In-Store Payment Functionality in China for AR Glasses in Collaboration with Rokid to Build Immersive Commerce18.6.2025 02:27:00 CEST | Press release
Over 250,000 units of Rokid Glasses have already been ordered, integrated with Alipay’s digital payment technology for AR glasses.The integration of payments into AR glasses supports a future of seamless, intuitive commerce—enabling instant, gesture-based transactions, immersive product discovery, and new ways for businesses to engage customers. Rokid, a pioneer in augmented reality (AR), today launched Rokid Glasses, its latest AR device. In China, the product supports in-store payments facilitated by Alipay’s digital payment technology and multidimensional risk control solution for AR glasses, providing a seamless and secure payment experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617845457/en/ Rokid partners with Alipay to launch China’s first AR glasses with in-store payment capabilities. According to Rokid, the product will begin rolling out to users starting in June 2025, with over 250,000 units already or
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom